BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 30312118)

  • 1. A Randomized Controlled Trial of Exercise to Prevent Bone Loss in Premenopausal Women with Breast Cancer.
    Tabatabai LS; Bloom J; Stewart S; Sellmeyer DE
    J Womens Health (Larchmt); 2019 Jan; 28(1):87-92. PubMed ID: 30312118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of supervised and home exercise training on bone mineral density among breast cancer patients. A 12-month randomised controlled trial.
    Saarto T; Sievänen H; Kellokumpu-Lehtinen P; Nikander R; Vehmanen L; Huovinen R; Kautiainen H; Järvenpää S; Penttinen HM; Utriainen M; Jääskeläinen AS; Elme A; Ruohola J; Palva T; Vertio H; Rautalahti M; Fogelholm M; Luoto R; Blomqvist C
    Osteoporos Int; 2012 May; 23(5):1601-12. PubMed ID: 21892676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact + resistance training improves bone health and body composition in prematurely menopausal breast cancer survivors: a randomized controlled trial.
    Winters-Stone KM; Dobek J; Nail LM; Bennett JA; Leo MC; Torgrimson-Ojerio B; Luoh SW; Schwartz A
    Osteoporos Int; 2013 May; 24(5):1637-46. PubMed ID: 22996743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy.
    Gnant M; Mlineritsch B; Luschin-Ebengreuth G; Kainberger F; Kässmann H; Piswanger-Sölkner JC; Seifert M; Ploner F; Menzel C; Dubsky P; Fitzal F; Bjelic-Radisic V; Steger G; Greil R; Marth C; Kubista E; Samonigg H; Wohlmuth P; Mittlböck M; Jakesz R;
    Lancet Oncol; 2008 Sep; 9(9):840-9. PubMed ID: 18718815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of power and strength training on bone mineral density in premenopausal women.
    Gray M; Di Brezzo R; Fort IL
    J Sports Med Phys Fitness; 2013 Aug; 53(4):428-36. PubMed ID: 23828291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercise effects on bone mineral density in women with breast cancer receiving adjuvant chemotherapy.
    Schwartz AL; Winters-Stone K; Gallucci B
    Oncol Nurs Forum; 2007 May; 34(3):627-33. PubMed ID: 17573321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of high-impact exercise on bone mineral density: a randomized controlled trial in premenopausal women.
    Vainionpää A; Korpelainen R; Leppäluoto J; Jämsä T
    Osteoporos Int; 2005 Feb; 16(2):191-7. PubMed ID: 15221206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in Bone Mineral Density in Women With Breast Cancer: A Prospective Cohort Study.
    Kim SH; Cho YU; Kim SJ; Han MS
    Cancer Nurs; 2019; 42(2):164-172. PubMed ID: 30802224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zoledronic acid prevents bone loss in premenopausal women with early breast cancer undergoing adjuvant chemotherapy: a phase III trial of the Korean Cancer Study Group (KCSG-BR06-01).
    Kim JE; Ahn JH; Jung KH; Kim SB; Kim HJ; Lee KS; Ro JS; Park YH; Ahn JS; Im YH; Im SA; Lee MH; Kim SY
    Breast Cancer Res Treat; 2011 Jan; 125(1):99-106. PubMed ID: 20922564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women.
    Powles TJ; Hickish T; Kanis JA; Tidy A; Ashley S
    J Clin Oncol; 1996 Jan; 14(1):78-84. PubMed ID: 8558225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of zoledronic acid versus placebo on bone mineral density and bone texture analysis assessed by the trabecular bone score in premenopausal women with breast cancer treatment-induced bone loss: results of the ProBONE II substudy.
    Kalder M; Kyvernitakis I; Albert US; Baier-Ebert M; Hadji P
    Osteoporos Int; 2015 Jan; 26(1):353-60. PubMed ID: 25381047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-year follow-up results of aerobic and impact training on bone mineral density in early breast cancer patients.
    Vehmanen L; Sievänen H; Kellokumpu-Lehtinen P; Nikander R; Huovinen R; Ruohola J; Penttinen HM; Utriainen M; Tokola K; Blomqvist C; Saarto T
    Osteoporos Int; 2021 Mar; 32(3):473-482. PubMed ID: 32886189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of resistance training on regional and total bone mineral density in premenopausal women: a randomized prospective study.
    Lohman T; Going S; Pamenter R; Hall M; Boyden T; Houtkooper L; Ritenbaugh C; Bare L; Hill A; Aickin M
    J Bone Miner Res; 1995 Jul; 10(7):1015-24. PubMed ID: 7484276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three year followup of bone mineral density change in premenopausal women with systemic lupus erythematosus.
    Kipen Y; Briganti E; Strauss B; Will R; Littlejohn G; Morand E
    J Rheumatol; 1999 Feb; 26(2):310-7. PubMed ID: 9972964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Osteogenic Effect of Impact-Loading and Resistance Exercise on Bone Mineral Density in Middle-Aged and Older Men: A Pilot Study.
    Bolam KA; Skinner TL; Jenkins DG; Galvão DA; Taaffe DR
    Gerontology; 2015; 62(1):22-32. PubMed ID: 26226987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of physical activity on bone strength and body composition in breast cancer premenopausal women during endocrine therapy.
    Hojan K; Milecki P; Molińska-Glura M; Roszak A; Leszczyński P
    Eur J Phys Rehabil Med; 2013 Jun; 49(3):331-9. PubMed ID: 23438652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in bone mineral density during 5 years of adjuvant treatment in premenopausal breast cancer patients.
    Kim M; Kim H; Ahn SH; Tabatabaie V; Choi SW; Sohn G; Lee SB; Ko BS; Chung IY; Kim J; Lee JW; Son BH; Kim HJ
    Breast Cancer Res Treat; 2020 Apr; 180(3):657-663. PubMed ID: 32072339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zoledronic acid prevents bone loss in premenopausal women undergoing adjuvant chemotherapy for early-stage breast cancer.
    Hershman DL; McMahon DJ; Crew KD; Cremers S; Irani D; Cucchiara G; Brafman L; Shane E
    J Clin Oncol; 2008 Oct; 26(29):4739-45. PubMed ID: 18711172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of breast cancer treatment-induced bone loss in premenopausal women treated with zoledronic acid: Final 5-year results from the randomized, double-blind, placebo-controlled ProBONE II trial.
    Kyvernitakis I; Kann PH; Thomasius F; Hars O; Hadji P
    Bone; 2018 Sep; 114():109-115. PubMed ID: 29908297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of chemotherapy and different chemotherapy regimens on bone health among Chinese breast cancer women in different menstrual status: a self-control study.
    Peng BQ; Wu J; Tian S; Qu XQ; Liang XY; Feng JH; Chen YL; She RL; Ma CY; Song JY; Li ZX; Jiang ZY; Wu KN; Kong LQ
    Support Care Cancer; 2023 Aug; 31(9):540. PubMed ID: 37642751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.